ARX Director Corrects Form 3: 165,831 Options at $19.31 Strike
Accelerant Holdings (ARX) – Form 3/A: Director Paul Christopher Little discloses ownership of a single stock-option grant covering 165,831 Class A shares with a $19.31 exercise price.
Rhea-AI Filing Summary
Accelerant Holdings (ARX) – Form 3/A: Director Paul Christopher Little discloses ownership of a single stock-option grant covering 165,831 Class A shares with a $19.31 exercise price. Twenty-five percent vests after one year; the remaining 75% vests in 6.25% quarterly installments over the next three years, contingent on continued service. This amendment corrects the prior Form 3 filed 23 Jul 2025, reducing the option by one share and increasing the exercise price by $0.01. No other equity positions or material changes are reported.
Positive
- None.
Negative
- None.
Insights
TL;DR: Minor clerical fix; insider ownership essentially unchanged—negligible market impact.
The filing merely amends Director Paul C. Little’s initial Form 3 to state the precise option size (165,831 vs. previously overstated by one share) and exact strike ($19.31, not $19.30). Vesting and service conditions remain standard for director compensation. As the adjustment is de minimis relative to Accelerant’s share count and does not indicate new buying or selling, it carries no valuation or governance signal. I view the disclosure as routine housekeeping.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Footnotes (1)
- F1. Twenty-five percent (25%) of the Class A Common Shares subject to the option vested on the one-year anniversary of the first day of the first month following the vesting commencement date, and the remaining Class A Common Shares subject to the option vest in 6.25% quarterly installments on each of the 12 subsequent 3-month anniversaries of the vesting commencement date, in each case subject to the Reporting Person's continuous service.
FAQ
What was corrected in Accelerant Holdings' (ARX) Form 3/A?
Who is the reporting person in this Form 3/A?
What is the vesting schedule for the reported stock option?
Is this filing expected to impact ARX’s stock price?
AI-generated analysis. How Rhea-AI works. Not financial advice.